Molecular Templates to Present at Three March Investor Conferences

AUSTIN, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will present a corporate overview at the Cowen & Company 40th Annual Health Care Conference, the Barclays Global Healthcare Conference, and the Oppenheimer 30th Annual Healthcare Conference.

Cowen & Company 40th Annual Health Care Conference
Date:		Monday, March 2
Time:		3:30pm Eastern Time
Webcast:		Click here for webcast
Barclays Global Healthcare Conference
Date:		Wednesday, March 11
Time:		4:50pm Eastern Time
Oppenheimer & Co. 30th Annual Healthcare Conference
Date:		Wednesday, March 18
Time:		1:00pm Eastern Time

About Molecular Templates  Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:Adam CutlerChief Financial Officer[email protected]  862-204-4006

Source: Molecular Templates, Inc.

Source: Molecular Templates, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackwells Capital Issues Statement on Braemar Hotels & Resorts
• How HOZO Tools Are Being Redefined by the 3D Printing Community
• Ress Life Investments A/S publishes Net Asset Value (NAV).